A copy of the article’s visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.
. 2020 Aug 10;4(15):3668. doi: 10.1182/bloodadvances.2020002987
Von Drygalski A, Giermasz A, Castaman G, et al. Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Adv. 2019;3(21):3241-3247.
Received 2020 Jul 17; Accepted 2020 Jul 17; Collection date 2020 Aug 11.
© 2020 by The American Society of Hematology
PMCID: PMC7422115 PMID: 32777062
This corrects the article "Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B" in volume 3 on page 3241.